Subscribe
Sign up for timely perspectives delivered to your inbox.
Investing by Prescription: Healthcare and Biotechnology
Find out from Andy Acker (portfolio manager and head of our global healthcare equities team) which current developments are particularly promising for him at the moment and why active portfolio management is so crucial, especially in the healthcare and biotechnology sector. Take a look behind the scenes as Eva Schaefer-Jansen (Head of Investor Relations at Sanofi) gives a rare insight into the company's current research work. From practice – for practice: Joachim Kopp (Executive Director of J.P. Morgan Private Bank in Frankfurt) will describe his experiences from customer discussions on the sector and explain why healthcare can be an important building block in customer portfolios.
26 Sep 2023
1 minute watch
1 minute watch